CCCLBSEConsolidated Construction Consortium Ltd· RealtyHighNeutral
Announced Tue, 17 Feb, 2026 · 15:43 IST

Consolidated Construction Consortium Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/02/2026 ,inter alia, to consider and approve fund ....

CCCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.4%Reaction day
₹17.28
prior close
₹17.05
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+2.1% vs market
Residential Commercial Projects peers, median of 61sector+0.2%+2.3% vs sector

On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 2.3 pts more than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+3.5
10m
+3.5
15m
+2.3
30m
+1.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.4+0.3+2.1+0.2+2.3
Next day
+0.7-1.1+1.8-0.9+1.6
2d
+2.4-1.3+3.7-1.2+3.7
3d
-4.2-1.1-3.1-1.5-2.7
4d
-4.9-2.4-2.5-3.6-1.3
5d
-6.7-2.2-4.4-3.4-3.3
1w
-9.1-3.0-6.1-3.3-5.8
15d
-8.1-7.5-0.6-11.9+3.8
1m
-9.8-7.4-2.4-12.0+2.2
2m
+3.6+1.9+1.7-1.2+4.8
3m
-15.3+3.6-18.9-5.9-9.4
UpDownMarket · Nifty Microcap 250Sector · Residential Commercial Projects peers, median of 61Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CCCL's Board is meeting on 21 February 2026 to finalise the preferential allotment of equity shares to raise up to ₹98.90 crores from Mark AB Capital. The investor was originally named Mark A B Capital Investment LLC, but a corrigendum on 3 February 2026 changed it to the Indian arm, Mark AB Capital Private Limited. The Board will consider this name change and decide on the number of shares (or convertible instruments including warrants) to be issued, along with the revised valuation report and revised relevant date. The allotment remains subject to shareholder and other regulatory approvals.

Likely market impact

If approved, this will bring in a new significant shareholder and result in dilution for existing public shareholders. The capital infusion could strengthen the company's balance sheet, but the stock may see short-term pressure on account of dilution.